Kay NE - Search Results

1

Mosaic chromosomal alterations (mCAs) in individuals with monoclonal B-cell lymphocytosis (MBL).

Sekar A, Griffin R, Parikh SA, Genovese G, Robinson DP, Norman AD, Olson JE, Rabe KG, Hoel MS, Boddicker NJ, Hampel PJ, Kay NE, Cerhan JR, Braggio E, Hanson CA, Vachon CM, Shanafelt TD, Ebert BL, Slager SL. Sekar A, et al. Among authors: kay ne. Blood Cancer J. 2024 Nov 6;14(1):193. doi: 10.1038/s41408-024-01175-8. Blood Cancer J. 2024. PMID: 39505849 Free PMC article.

2

Evidence that large granular lymphocytes from B-CLL patients with hypogammaglobulinemia down-regulate B-cell immunoglobulin synthesis.

Kay NE, Perri RT. Kay NE, et al. Blood. 1989 Mar;73(4):1016-9. Blood. 1989. PMID: 2784065 Free article.

3

The malignant B cells from B-chronic lymphocytic leukemia patients release TAC-soluble interleukin-2 receptors.

Kay NE, Burton J, Wagner D, Nelson DL. Kay NE, et al. Blood. 1988 Aug;72(2):447-50. Blood. 1988. PMID: 3135858 Free article.

4

Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia.

Jelinek DF, Tschumper RC, Geyer SM, Bone ND, Dewald GW, Hanson CA, Stenson MJ, Witzig TE, Tefferi A, Kay NE. Jelinek DF, et al. Among authors: kay ne. Br J Haematol. 2001 Dec;115(4):854-61. doi: 10.1046/j.1365-2141.2001.03149.x. Br J Haematol. 2001. PMID: 11843819 Free article.

5

Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients.

Fonseca R, Blood EA, Oken MM, Kyle RA, Dewald GW, Bailey RJ, Van Wier SA, Henderson KJ, Hoyer JD, Harrington D, Kay NE, Van Ness B, Greipp PR. Fonseca R, et al. Among authors: kay ne. Blood. 2002 May 15;99(10):3735-41. doi: 10.1182/blood.v99.10.3735. Blood. 2002. PMID: 11986230 Free article.

6

B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules.

Kay NE, Bone ND, Tschumper RC, Howell KH, Geyer SM, Dewald GW, Hanson CA, Jelinek DF. Kay NE, et al. Leukemia. 2002 May;16(5):911-9. doi: 10.1038/sj.leu.2402467. Leukemia. 2002. PMID: 11986954

7

B-CLL: is the enigma of disease heterogeneity about to be revealed?

Kay NE, Jelinek DF. Kay NE, et al. Blood. 2002 Aug 15;100(4):1110-1. doi: 10.1182/blood.V100.4.1110b. Blood. 2002. PMID: 12149185 Free article. No abstract available.

8

Anthropometric characteristics, physical activity, and risk of non-Hodgkin's lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective study.

Cerhan JR, Janney CA, Vachon CM, Habermann TM, Kay NE, Potter JD, Sellers TA, Folsom AR. Cerhan JR, et al. Among authors: kay ne. Am J Epidemiol. 2002 Sep 15;156(6):527-35. doi: 10.1093/aje/kwf082. Am J Epidemiol. 2002. PMID: 12226000

9

Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival.

Novak AJ, Bram RJ, Kay NE, Jelinek DF. Novak AJ, et al. Among authors: kay ne. Blood. 2002 Oct 15;100(8):2973-9. doi: 10.1182/blood-2002-02-0558. Blood. 2002. PMID: 12351410 Free article.

10

Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia.

Dewald GW, Brockman SR, Paternoster SF, Bone ND, O'Fallon JR, Allmer C, James CD, Jelinek DF, Tschumper RC, Hanson CA, Pruthi RK, Witzig TE, Call TG, Kay NE. Dewald GW, et al. Among authors: kay ne. Br J Haematol. 2003 Apr;121(2):287-95. doi: 10.1046/j.1365-2141.2003.04265.x. Br J Haematol. 2003. PMID: 12694251 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

460 results

Search Page

Filters